Ricardo L M Duarte1,2, Fernanda C Q Mello3, Flavio J Magalhães-da-Silveira4, Tiago S Oliveira-E-Sá5,6, Marcelo F Rabahi7, David Gozal8. 1. Sleep - Laboratório de Estudo dos Distúrbios do Sono, Centro Médico BarraShopping, Avenida das Américas 4666, sala 309, Barra da Tijuca, Rio de Janeiro, 22649-900, Brazil. rlmduarte@gmail.com. 2. Instituto de Doenças do Tórax - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. rlmduarte@gmail.com. 3. Instituto de Doenças do Tórax - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. 4. Sleep - Laboratório de Estudo dos Distúrbios do Sono, Centro Médico BarraShopping, Avenida das Américas 4666, sala 309, Barra da Tijuca, Rio de Janeiro, 22649-900, Brazil. 5. Hospital de Santa Marta - Centro Hospitalar Lisboa Central, Lisbon, Portugal. 6. NOVA Medical School - Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal. 7. Faculdade de Medicina, Universidade Federal de Goiás, Goiás, Brazil. 8. Department of Child Health, University of Missouri School of Medicine, Columbia, MO, USA.
Abstract
PURPOSE: Obstructive sleep apnea (OSA) is very common occurrence among morbidly obese patients. Our main objectives were to validate the No-Apnea, a 2-item screening tool, in morbidly obese patients and compare its performance with three other instruments: STOP-Bang questionnaire, NoSAS score, and Epworth Sleepiness Scale (ESS). METHODS: A cross-sectional analysis of morbidly obese patients (body mass index [BMI] ≥ 35.0 kg/m2) grouped into two independent samples: bariatric surgery patients (BS) and non-bariatric surgery patients (NBS). All patients underwent overnight polysomnography. Discriminatory ability was assessed by area under the curve (AUC). OSA severity was defined by apnea/hypopnea index cut-off points: ≥ 5.0/h (OSA≥5), ≥ 15.0/h (OSA≥15), and ≥ 30.0/h (OSA≥30). RESULTS: A total of 1017 subjects (40.4% in BS cohort and 59.6% in NBS cohort) were evaluated. In the BS cohort, No-Apnea had similar discrimination to STOP-Bang and NoSAS for predicting OSA≥5 (p = 0.979 and p = 0.358, respectively), OSA≥15 (p = 0.158 and p = 0.399, respectively), and OSA≥30 (p = 0.388 and p = 0.903, respectively). In the NBS cohort, No-Apnea had similar discrimination to STOP-Bang and NoSAS for predicting OSA≥5 (p = 0.528 and p = 0.428, respectively), OSA≥15 (p = 0.825 and p = 0.108, respectively), and OSA≥30 (p = 0.458 and p = 0.186, respectively). Moreover, No-Apnea performed significantly better than ESS in both BS and NBS cohorts (p < 0.001). CONCLUSIONS: No-Apnea is a useful and practical tool for screening of OSA in morbidly obese patients, with non-inferior performance to STOP-Bang questionnaire and NoSAS score.
PURPOSE:Obstructive sleep apnea (OSA) is very common occurrence among morbidly obesepatients. Our main objectives were to validate the No-Apnea, a 2-item screening tool, in morbidly obesepatients and compare its performance with three other instruments: STOP-Bang questionnaire, NoSAS score, and Epworth Sleepiness Scale (ESS). METHODS: A cross-sectional analysis of morbidly obesepatients (body mass index [BMI] ≥ 35.0 kg/m2) grouped into two independent samples: bariatric surgery patients (BS) and non-bariatric surgery patients (NBS). All patients underwent overnight polysomnography. Discriminatory ability was assessed by area under the curve (AUC). OSA severity was defined by apnea/hypopnea index cut-off points: ≥ 5.0/h (OSA≥5), ≥ 15.0/h (OSA≥15), and ≥ 30.0/h (OSA≥30). RESULTS: A total of 1017 subjects (40.4% in BS cohort and 59.6% in NBS cohort) were evaluated. In the BS cohort, No-Apnea had similar discrimination to STOP-Bang and NoSAS for predicting OSA≥5 (p = 0.979 and p = 0.358, respectively), OSA≥15 (p = 0.158 and p = 0.399, respectively), and OSA≥30 (p = 0.388 and p = 0.903, respectively). In the NBS cohort, No-Apnea had similar discrimination to STOP-Bang and NoSAS for predicting OSA≥5 (p = 0.528 and p = 0.428, respectively), OSA≥15 (p = 0.825 and p = 0.108, respectively), and OSA≥30 (p = 0.458 and p = 0.186, respectively). Moreover, No-Apnea performed significantly better than ESS in both BS and NBS cohorts (p < 0.001). CONCLUSIONS: No-Apnea is a useful and practical tool for screening of OSA in morbidly obesepatients, with non-inferior performance to STOP-Bang questionnaire and NoSAS score.
Authors: Adeline Tan; Yueheng Hong; Linda W L Tan; Rob M van Dam; Yan Yi Cheung; Chi-Hang Lee Journal: Sleep Breath Date: 2017-01-07 Impact factor: 2.816
Authors: Richard B Berry; Rohit Budhiraja; Daniel J Gottlieb; David Gozal; Conrad Iber; Vishesh K Kapur; Carole L Marcus; Reena Mehra; Sairam Parthasarathy; Stuart F Quan; Susan Redline; Kingman P Strohl; Sally L Davidson Ward; Michelle M Tangredi Journal: J Clin Sleep Med Date: 2012-10-15 Impact factor: 4.062
Authors: Wing Tai Kong; Shawn Chopra; Michael Kopf; Carlos Morales; Shahzad Khan; Keith Zuccala; Laura Choi; John Chronakos Journal: Obes Surg Date: 2016-12 Impact factor: 4.129
Authors: Ricardo L M Duarte; Marcelo F Rabahi; Flavio J Magalhães-da-Silveira; Tiago S de Oliveira-E-Sá; Fernanda C Q Mello; David Gozal Journal: J Clin Sleep Med Date: 2018-07-15 Impact factor: 4.062
Authors: Ricardo L M Duarte; Flavio J Magalhães-da-Silveira; Tiago S Oliveira-E-Sá; Marcelo F Rabahi; Fernanda C Q Mello; David Gozal Journal: Lung Date: 2019-05-10 Impact factor: 2.584
Authors: Kimberly Y Kreitinger; Macy M S Lui; Robert L Owens; Christopher N Schmickl; Eduardo Grunvald; Santiago Horgan; Janna R Raphelson; Atul Malhotra Journal: Obesity (Silver Spring) Date: 2020-11 Impact factor: 5.002
Authors: Christianne C A F M Veugen; Emma M Teunissen; Leontine A S den Otter; Martijn P Kos; Robert J Stokroos; Marcel P Copper Journal: Sleep Breath Date: 2020-10-24 Impact factor: 2.816
Authors: Javier Lázaro; Paloma Clavería; Carmen Cabrejas; José Fernando; Berta Daga; Beatriz Ordoñez; Silvia Segura; David Sanz-Rubio; José M Marín Journal: Respir Res Date: 2020-02-04